Most Popular Stories

Share This Page

: SPY |  News, Ratings, and Charts

The WORST Stock Market Ever!

It’s been a while since I talked to anyone enjoying the recent stock market action. Too volatile. Too illogical. No real trend. All true. However, the more we understand why this is happening the easier to diagnose what will happen from here and how we can trade our way to profits. (Spoiler Alert) I am still bearish. Gladly I still see 7 timely trades to use to make money as the S&P 500 (SPY) heads lower from here. Read on below for the full story…

: CRM |  News, Ratings, and Charts

This Software Stock Just Flashed a Buy Signal

Shares of cloud software maker Salesforce (CRM) have gained more than 40% over the past three months. Outstanding financial performance and a bullish outlook, with growing AI integration, have recently driven investor sentiment around CRM. Hence, this software stock might be an ideal buy considering its promising growth prospects and high profitability. Keep reading…

: GILD |  News, Ratings, and Charts

3 Stocks with More Upside Potential

Coupled with macroeconomic headwinds, the sudden regional banking failures have marred investor sentiments. Moreover, amid anticipations of a recession, the existing market volatilities are not likely to subside anytime soon. Given this backdrop, we think the strong growth prospects of Gilead Sciences (GILD), Teva Pharmaceutical (TEVA), and MacroGenics (MGNX) make these stocks wise portfolio additions now. Read on…

: ABBV |  News, Ratings, and Charts

2 Top Stocks That Should Be on Your Radar This Spring

Amidst the turmoil in the banking sector, high inflation, and the Fed’s restrictive monetary policy, the economy faces a threat of recession this year. However, fundamentally strong stocks AbbVie (ABBV) and Salesforce (CRM) might be worth adding to your watchlist. Read more...

: SPY |  News, Ratings, and Charts

REVISED: 2023 Stock Market Outlook

40 year investment veteran Steve Reitmeister shares his most complete and up to the minute analysis of what lies ahead for investors the rest of 2023. First a return of the nasty bear market with the S&P 500 (SPY) making news lows. Yet just at the darkest hour the new bull market will emerge ushering in tremendous gains to investors who time it right. Steve shares his trading plan along with top 7 picks to profit on the way to bear market bottom. Next he shares a plan to buy the market bottom with 2 top picks set to rally 100%+. Get the full story below....

Top Stories


NYSE: SPY | SPDR S&P 500 ETF Trust News, Ratings, and Charts

Why This Key Buy Signal Is Making Me Nervous About Current Market Conditions…

This week, we had the latest meeting by the Federal Reserve. The central bank raised interest rates by 25 basis points, and indicated that we're likely close to a pause. You'd imagine the stock market (SPY) would cheer... But I'm seeing something else that's making me nervous. Read on...

NYSE: V | Visa Inc. CI A News, Ratings, and Charts

2 Robinhood Stocks to Buy and Hold Forever

Popular brokerage company Robinhood (HOOD) attracts millennials and Generation Z traders by offering zero-commission financial services. While not all stocks traded on this platform possess fundamental strength, investors could consider buying fundamentally sound Robinhood stocks Visa (V) and Pfizer (PFE) and holding them for the long term. Keep reading…

NYSE: WMT | Walmart Inc. News, Ratings, and Charts

3 Stocks You'll Never Regret Buying

The Federal Reserve this week increased interest rates for the ninth time since last year and shows no indication of rate cuts this year despite lingering recession fears. As the macroeconomic backdrop remains uncertain, investors could consider buying fundamentally strong, dividend-paying stocks Walmart (WMT), Elevance Health (ELV), and Canon (CAJ) for solid gains. Continue reading…

NASDAQ: VRTX | Vertex Pharmaceuticals Inc. News, Ratings, and Charts

4 Biotech Stocks You Don’t Want to Miss out on in 2023

The biotech industry is growing with considerable developments and government initiatives. Given the solid prospects of the industry, fundamentally sound biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Exelixis (EXEL), and Cidara Therapeutics (CDTX) could be excellent buys. Keep reading...

: WBD | Warner Bros. Discovery Inc. Series A News, Ratings, and Charts

3 Streaming Stocks You Want No Part Of

Streaming stocks faced a rough year in 2022 as subscriber growth slowed amid concerns about high inflation and macro uncertainties. Therefore, it could be wise to avoid fundamentally weak streaming stocks Warner Bros. (WBD), Paramount Global (PARA), and World Wrestling (WWE), given their weak fundamentals. Read more…

NYSE: JNJ | Johnson & Johnson News, Ratings, and Charts

3 Popular Large-Cap Stocks to Buy Right Now

As investors continue to digest the news of the recent bank collapses and the Federal Reserve’s quarter-percentage-point rate hike, the stock market outlook seems bumpy for some time. With speculations of an economic slowdown, investing in prominent large-cap stocks Johnson & Johnson (JNJ), Visa (V), and Merck & Co. (MRK) could now help beat the downturn. Keep reading…

NYSE: MCK | McKesson Corp. News, Ratings, and Charts

4 Medical Stocks That Could Help Make You a Small Fortune

The medical industry has undergone significant expansion in recent times, and is projected to continue growing due to the increasing number of chronic diseases and the swift adoption of technology. Hence, I think fundamentally strong medical stocks McKesson (MCK), Centene (CNC), Cardinal Health (CAH), and Nature’s Sunshine Products (NATR) might help make a fortune. Read on...

NYSE: NOK | Nokia Corp. ADR News, Ratings, and Charts

4 Penny Stocks to Pick up This Week

The Fed’s hawkish stance, coupled with the recent banking-system tumult, will likely keep the stock market under some pressure. Given this backdrop, it would be wise if quality penny stocks Nokia Oyj (NOK), Rimini Street (RMNI), Rave Restaurant Group (RAVE), and Data Storage Corporation (DTST) could be added to your portfolio this week. Read on…

NASDAQ: CSCO | Cisco Systems, Inc. News, Ratings, and Charts

1 Tech Stock You Can Buy Now and Hold for 20 Years

Shares of prominent tech company Cisco Systems (CSCO) are trading above its 50 and 200-day moving averages. Moreover, the company has a significant dividend paying record. I think the stock might be a solid buy for the long term. Let’s discuss why...

NYSE: SHOP | Shopify Inc. Cl A News, Ratings, and Charts

Is It Too Late to Buy SHOP Stock?

Although Shopify (SHOP) delivered top-line growth in the last reported quarter and gained 32% year-to-date, let’s see if the stock still has any upside left despite the expected pressure on the bottom line. Read on…

NYSE: CRM | Salesforce.com Inc News, Ratings, and Charts

3 Hypergrowth Stocks to Buy for Big Gains In 2023

The recent financial-sector turmoil, the Fed’s hawkish tilt, and growing recession worries paint a gloomy picture for the stock market. Despite the headwinds, investors shouldn’t shy away from buying top-notch growth stocks Salesforce (CRM), AGCO (AGCO), and Cars.com (CARS), with solid fundamentals and the ability to deliver market-beating returns this year. Read on…


NYSE: JNJ | Johnson & Johnson News, Ratings, and Charts

3 Large-Cap Pharma Stocks to Protect Your Portfolio Through 2023

The worst banking crisis since 2008 could not stop the Fed from raising the benchmark interest rate. The possibility of further policy tightening and strict lending standards for banks might push the economy into a recession this year. Therefore, investing in large-cap pharma stocks Johnson & Johnson (JNJ), Merck & Co. (MRK), and Bristol-Myers Squibb (BMY) could help protect your portfolio. Read more…

NYSE: JNJ | Johnson & Johnson News, Ratings, and Charts

4 Best Pharma Stocks to Buy for the Long Haul

With the persistent rise in lifestyle diseases, the pharmaceutical industry is well poised for strong growth in the long term. Also, with the Fed likely to keep increasing the interest rates, the economy is likely to enter a recession, making pharma stocks attractive investment options. Therefore, investors could look to buy fundamentally strong pharma stocks Johnson & Johnson (JNJ), AstraZeneca (AZN), Novartis (NVS), and Bristol-Myers Squibb (BMY). Keep reading...

: ZM | Zoom Video Communications, Inc. - News, Ratings, and Charts

1 Stock That Profits From the Rise of Remote Work

Video conferencing software company Zoom Video (ZM) posted better-than-expected fourth-quarter results and provided a positive earnings outlook for the current quarter. Moreover, given the rise in demand for technology and services supporting remote work, the stock might be an ideal buy. Keep reading...

NYSE: MPC | Marathon Petroleum Corp. News, Ratings, and Charts

Don't Miss the Momentum on These 4 Energy Stocks

With indications of a more considerate monetary stance from the Fed, energy stocks Marathon Petroleum (MPC), Valero Energy (VLO), Halliburton (HAL), and NexTier Oilfield Solutions (NEX) could be attractive investments to benefit from an expected uptick in energy prices. Continue reading…

NYSE: PEP | PepsiCo, Inc. News, Ratings, and Charts

3 Beverage Stocks to Buy More of in 2023

Amid the growing customer preference for healthier drinks, the beverage sector is predicted to survive the ongoing macroeconomic challenges on the backs of stable demand. In light of this, quality beverage stocks PepsiCo (PEP), Anheuser-Busch (BUD), and Primo Water Corp. (PRMW) might be solid picks in 2023. Read more…

NYSE: CCL | Carnival Corporation  News, Ratings, and Charts

Sell the Cruises, Buy This Travel Stock Instead

The travel industry witnessed a solid post-pandemic rebound last year and is poised for significant growth in the foreseeable future, driven by pent-up travel demand. However, given the challenging macro environment, avoiding struggling cruise stocks Carnival Corporation (CCL) and Norwegian Cruise (NCLH) could be wise. Instead, investors could consider buying the fundamentally sound travel stock Playa Hotels (PLYA). Keep reading…

NYSE: JNJ | Johnson & Johnson News, Ratings, and Charts

The Strongest Pharma Stock This Week

Tighter bank lending and the Fed’s continued fight against inflation will likely push the economy into a recession this year. In this scenario, investors can look to invest in the pharma giant Johnson & Johnson (JNJ), given its financial strength, reliable dividend payments, and solid growth prospects. Read more…

NASDAQ: GILD | Gilead Sciences Inc. News, Ratings, and Charts

2 Biotech Stocks to Buy Hand Over Fist in March

The biotech industry is expected to expand rapidly, driven by significant advancements and government initiatives. Furthermore, this sector tends to be relatively defensive and holds up relatively well during downturns. So, fundamentally sound biotech stocks Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) might be ideal buys now. Keep reading...

NYSE: MPC | Marathon Petroleum Corp. News, Ratings, and Charts

Fill up Your Portfolio With These 3 Gas Stocks

Regardless of the retreat in oil and gas prices from their peaks a year ago, resurgent global energy demand amid constrained supplies appears to be an enduring tailwind for U.S. energy producers. Hence, it could be wise to invest in fundamentally sound gas stocks, Marathon Petroleum (MPC), CVR Energy (CVI), and Epsilon Energy (EPSN). Read on…

Page generated in 2.1395 seconds.